MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202617082916 A) filed by Yichang Humanwell Pharmaceutical Co. , Ltd; and Wuhan Humanwell Innovative Drug Research And on July 06, 2026, for Nav1.8 Inhibitor Compound, Salt Thereof, Polymorph Thereof, And Use Thereof.
Inventors include Zhang, Xuejun; Li, Jinping; Zong, Qiao; Xia, Qingfeng; Chen, Haomin; Song, Xiaobo; Liu, Lifei; Yang, Jun; and Li, Li'E.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention relates to a Nav1.8 inhibitor compound, a salt thereof, a polymorph thereof, and the use thereof. The present invention provides a salt of a compound of formula (I), a compound of formula (I) and a crystal form of a salt thereof, which have good medicinal properties. The structure of the formula (I) is as follows:
Disclaimer: Curated by HT Syndication.
